ST. PETERSBURG, Fla., March 26 /PRNewswire-FirstCall/ -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc , is providing a web-based resource guide to medical reimbursement for its comprehensive line of advanced wound care products. The website is available now. Click here to view the site.
"Smith & Nephew is committed to supporting its customers as they navigate the reimbursement landscape," said Randall Carson, Director of Health Policy & Reimbursement at Smith & Nephew, North American Advanced Wound Management. "With questions and input from clinicians, we aim to maintain a robust, up-to-date, one-stop resource that clinicians can turn to often as a reference tool as well as for guidance on new or evolving areas of wound care reimbursement."
The wound care reimbursement site is part of www.smith-nephew.com/reimbursement, which includes reimbursement information for the total portfolio of Smith & Nephew products, including products from its endoscopy and orthopaedic divisions.
About Us
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2009 were nearly $3.8 billion.
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
CONTACT: media, Steve DiMattia, Managing Director of EVC Group, Inc.,
+1-646-201-5445, for Smith & Nephew; or Tom Dugan, North American President
of Smith & Nephew Advanced Wound Management, +1-727-399-3766; or investors,
Liz Hewitt, Group Director, Corporate Affairs of Smith & Nephew, + 44 (0)
207-401-7646
Web site: http://www.smith-nephew.com//